SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doc Bones who wrote (254)2/12/2000 3:27:00 PM
From: Jim Oravetz  Read Replies (3) of 523
 
Kind of OT, but doesn't seem odd that a Growth and Income fund would be sinking $45M into a biotech issue that has no earning? Without looking at their portfolio, maybe they have billions of $, and this amount is pocket change. What about following the investment style outlined in the prospectus? Do they disclose that they invest in this kind of company to the shareholders?

I'm glad I am now looking at companies myself, rather than mutuals. (except for 401k stuff).
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News